The NECTA Drug Development Meeting 2026 values the support of industry and government partners in hosting this landmark event.
With thanks to our sponsorship partners for 2026:
With thanks to our sponsorship partners for 2026:
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications. Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine
Sponsorship packages for the upcoming Meeting are currently available.
Please contact the Organising Committee for further details on sponsorship options at: [email protected]
Please contact the Organising Committee for further details on sponsorship options at: [email protected]